Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Dead/Cancelled
CANCELLED - SECTION 8
CANCELLED - SECTION 8
section 8
on 12 Jan 2024
Last Applicant/ Owned by
PETER STREET
DUBLIN
IE
8
Serial Number
86980926 filed on 30th Sep 2015
Registration Number
5233627 registered on 27th Jun 2017
in the Principal Register
Correspondent Address
Jeffrey H. Handelsman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
SEBELA PHARMACEUTICALS INC.
Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders
First Use Date in General
31st Aug 2013
First Use Date in Commerce
31st Aug 2013
Specimens
Mark Details
Serial Number
No 86980926
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T51315
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Jan 2024 | CANCELLED SEC. 8 (6-YR) |
| 27th Jun 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 24th Jul 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 04th Jul 2018 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 27th Jun 2017 | REGISTERED-PRINCIPAL REGISTER |
| 24th May 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 23rd May 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 20th Apr 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 19th Apr 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 19th Apr 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |